Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$210 Hold
4
﹤0.01% 999
2026
Q1
$221 Hold
4
﹤0.01% 952
2025
Q4
$197 Sell
4
-55
-93% -$2.56K ﹤0.01% 916
2025
Q3
$2.55K Sell
59
-18
-23% -$703 ﹤0.01% 714
2025
Q2
$2.96K Hold
77
﹤0.01% 657
2025
Q1
$2.98K Buy
77
+73
+1,825% +$2.67K ﹤0.01% 667
2024
Q4
$136 Hold
4
﹤0.01% 929
2024
Q3
$164 Hold
4
﹤0.01% 957
2024
Q2
$154 Hold
4
﹤0.01% 757
2024
Q1
$172 Hold
4
﹤0.01% 686
2023
Q4
$149 Hold
4
﹤0.01% 687
2023
Q3
$145 Sell
4
-32
-89% -$1.14K ﹤0.01% 762
2023
Q2
$1.28K Hold
36
﹤0.01% 594
2023
Q1
$1.28K Sell
36
-40
-53% -$1.4K ﹤0.01% 558
2022
Q4
$2.67K Sell
76
-108
-59% -$3.6K ﹤0.01% 471
2022
Q3
$5K Sell
184
-226
-55% -$8.56K ﹤0.01% 606
2022
Q2
$22K Buy
410
+36
+10% +$1.99K 0.02% 373
2022
Q1
$20K Sell
374
-121
-24% -$6.57K 0.01% 422
2021
Q4
$27K Sell
495
-37
-7% -$1.93K 0.02% 371
2021
Q3
$25K Buy
532
+146
+38% +$7.33K 0.02% 384
2021
Q2
$19K Hold
386
0.01% 403
2021
Q1
$17K Buy
386
+67
+21% +$3.04K 0.01% 411
2020
Q4
$14K Buy
+319
New +$14.7K 0.01% 404

Other funds holding GSK

Wolff Wiese Magana's GSK Position: Q2 2026 in Review

Wolff Wiese Magana held its GSK (GSK) position steady in Q2 2026 at 4 shares worth $210. The position accounts for ﹤0.01% of the portfolio, ranked #999.

Wolff Wiese Magana first reported a position in GSK in Q4 2020 and has held it in 23 quarters since. The position peaked at $27K in Q4 2021. 161 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Wolff Wiese Magana held 4 shares of GSK worth $210 as of Q2 2026.
  • Wolff Wiese Magana left its GSK share count unchanged in Q2 2026.
  • GSK made up ﹤0.01% of Wolff Wiese Magana's portfolio in Q2 2026, its #999 holding.
  • Wolff Wiese Magana first reported a position in GSK in Q4 2020 and has held it in 23 quarters since.
  • Wolff Wiese Magana's GSK position peaked at $27K in Q4 2021.
  • 161 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.